Article Details

Asia Deal Watch: Regenxbio Licenses Two MPS Gene Therapies To Nippon Shinyaku

Retrieved on: 2025-01-16 21:49:26

Tags for this article:

Click the tags to see associated articles and topics

Asia Deal Watch: Regenxbio Licenses Two MPS Gene Therapies To Nippon Shinyaku. View article details on hiswai:

Excerpt

Insilico Medicine · Samsung Bioepis Co., Ltd. Teva Pharmaceutical Industries Ltd. AstraZeneca PLC · Johnson & Johnson · Vertex Pharmaceuticals ...

Article found on: scrip.pharmaintelligence.informa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo